Latest Breaking News On - ராபி ஜோமேற் - Page 11 : vimarsana.com

  MGC Pharmaceuticals Ltd (ASX: MXC or the Company )   advises the Company s Board and independent committees have, following the recent dual listing on the London Stock Exchange, and in conjunction with the Company s key advisors in the United Kingdom, agreed market appropriate changes to the remuneration and equity incentive structures of the Executive Directors and Key Management Personnel.  This includes a new performance rights program structured to retain the services of key personnel managing the Company s business and to bring in line with similar listed companies in the bio-pharma sector in the United Kingdom. In addition, the Company announces the change of Company Secretary, Mrs Narelle Warren resigning as Joint Company Secretary of the Company with an effective date of 07 April 2021.  The Board would like to express its appreciation to Mrs Warren for her contribution to the Company during her tenure which included the successful du

United statesUnited kingdomCity ofDaniel kendallBrett mitchellRoby zomerNarelle warrenRachel kerrLondon stock exchangeMs nadine barry as joint companyRemuneration committeeChieftain securities pty ltdPharmaceuticals ltdSibella capital pty ltdCompany boardChitta lu